Early day motion · EDM 2943 · 11 Mar 2026
Ketamine
Tabled by Grahame Morris (Labour)
13 signatures
The motion
That this House notes with concern the increased problematic use of ketamine, particularly among young people; further notes that its severe impacts can include cognitive impairment, psychological difficulties and physical damage to the bladder, kidneys and urinary tract, leading to dependency and contributing to deaths; recognises that those affected may require incontinence pads or surgery; pays tribute to those providing peer-support in friendly, safe groups free from stigma; supports the recommendations of the Advisory Council on the Misuse of Drugs (ACMD) advising against the reclassification of the drug from a Class B to a Class A controlled substance; recognises that previous punitive policies have proven to be ineffective and often counter-productive; advocates a public health-centred harm reduction approach, providing access to evidence-based education and effective treatment; and urges the Government to adopt the recommendations of the ACMD, raise awareness of ketamine-related harms and promote the expansion of education, treatment and support services.
Signatories (13)
-
Grahame Morris
Primary sponsor
11 Mar 2026 -
John McDonnell
11 Mar 2026 -
Brian Leishman
12 Mar 2026 -
Bob Blackman
13 Mar 2026 -
Carla Denyer
16 Mar 2026 -
Siân Berry
16 Mar 2026 -
Rachael Maskell
17 Mar 2026 -
Jim Shannon
17 Mar 2026 -
Ian Lavery
24 Mar 2026 -
Adam Dance
13 Apr 2026 -
Richard Burgon
22 Apr 2026 -
Bell Ribeiro-Addy
23 Apr 2026 -
Mary Glindon
28 Apr 2026
Source: the official Early Day Motions database.